Journal article Open Access

Global Surveillance Networks and International Health Regulations‎ in the ‎Early ‎Detection and Control of Epidemics‎

Güner, Öner


DataCite XML Export

<?xml version='1.0' encoding='utf-8'?>
<resource xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://datacite.org/schema/kernel-4" xsi:schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4.1/metadata.xsd">
  <identifier identifierType="URL">https://zenodo.org/record/5876878</identifier>
  <creators>
    <creator>
      <creatorName>Güner, Öner</creatorName>
      <givenName>Öner</givenName>
      <familyName>Güner</familyName>
      <nameIdentifier nameIdentifierScheme="ORCID" schemeURI="http://orcid.org/">0000-0003-4472-2008</nameIdentifier>
      <affiliation>Department of Infectious Disease and Clinical Microbiology, Faculty of Medicine, Ankara Yıldırım ‎Beyazıt University, Ankara, Turkey.</affiliation>
    </creator>
  </creators>
  <titles>
    <title>Global Surveillance Networks and International Health Regulations‎ in the ‎Early ‎Detection and Control of Epidemics‎</title>
  </titles>
  <publisher>Zenodo</publisher>
  <publicationYear>2022</publicationYear>
  <subjects>
    <subject>COVID-19</subject>
    <subject>Pandemi</subject>
    <subject>Sürveyans</subject>
    <subject>Erken uyarı</subject>
    <subject>Pandemic</subject>
    <subject>Surveillance</subject>
    <subject>Early warning‎</subject>
  </subjects>
  <dates>
    <date dateType="Issued">2022-01-18</date>
  </dates>
  <language>tr</language>
  <resourceType resourceTypeGeneral="JournalArticle"/>
  <alternateIdentifiers>
    <alternateIdentifier alternateIdentifierType="url">https://zenodo.org/record/5876878</alternateIdentifier>
  </alternateIdentifiers>
  <relatedIdentifiers>
    <relatedIdentifier relatedIdentifierType="DOI" relationType="IsIdenticalTo">10.54584/lms.2022.12</relatedIdentifier>
  </relatedIdentifiers>
  <rightsList>
    <rights rightsURI="https://creativecommons.org/licenses/by/4.0/legalcode">Creative Commons Attribution 4.0 International</rights>
    <rights rightsURI="info:eu-repo/semantics/openAccess">Open Access</rights>
  </rightsList>
  <descriptions>
    <description descriptionType="Abstract">&lt;p&gt;&lt;strong&gt;&amp;Ouml;zet&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;Bulaşıcı hastalık tehditlerine karşı bir siper olmak &amp;uuml;zere d&amp;uuml;nyada ayrıntılı bir k&amp;uuml;resel sağlık sistemi geliştirilmiştir. Sistem, farklı paydaşlara hizmet eden &amp;ccedil;eşitli resmi ve gayri resmi kuruluş ağlarından oluşur. Bu ağ farklı ama&amp;ccedil;lara, y&amp;ouml;ntemlere, kaynaklara ve hesap verebilirliğe sahip; farklı etki alanlarında (yerel, ulusal, b&amp;ouml;lgesel veya k&amp;uuml;resel d&amp;uuml;zeyde) faaliyet g&amp;ouml;steren kamu kuruluşları, k&amp;acirc;r ama&amp;ccedil;lı ve k&amp;acirc;r amacı g&amp;uuml;tmeyen &amp;ouml;zel sekt&amp;ouml;r kuruluşlarından oluşmaktadır. Mevcut k&amp;uuml;resel sağlık sistemi, insan sağlığını korumak ve iyileştirmek i&amp;ccedil;in &amp;ouml;nemli &amp;ccedil;alışmalar ger&amp;ccedil;ekleştirmiştir. Bununla birlikte, d&amp;uuml;nya uzun s&amp;uuml;redir devam eden ve yeni ortaya &amp;ccedil;ıkan veya yeniden &amp;ouml;nem kazanan bulaşıcı hastalık tehditleriyle karşı karşıya kalmaya devam etmektedir. Bu tehditler, ciddiyet durumu ve risk ihtimalleri a&amp;ccedil;ısından b&amp;uuml;y&amp;uuml;k farklılıklar g&amp;ouml;stermekte ve her biri i&amp;ccedil;in ayrı m&amp;uuml;cadele dinamikleri gerekmektedir. Ayrıca, hastalık ve &amp;ouml;l&amp;uuml;m oranlarında olduğu gibi, bu enfeksiyonların farklılaşan bir dizi karmaşık sosyal ve ekonomik etkileri ve sonu&amp;ccedil;ları da s&amp;ouml;z konusudur. Mevcut haliyle k&amp;uuml;resel sağlık sisteminin halihazırdaki bir dizi bulaşıcı hastalık tehdidine karşı etkili koruma sağlayıp sağlayamayacağı tartışılmaktadır. Son zamanlarda ortaya &amp;ccedil;ıkan Ebola, Zika, dang humması, Şiddetli Akut Solunum Sendromu (SARS), Orta Doğu Solunum Sendromu (MERS), COVID-19, grip salgınları ve artan antimikrobiyal diren&amp;ccedil; tehdidi nedeniyle bu sistem ciddi sınavlar vermektedir. Zayıf sağlık sistemleri, şehirleşme, k&amp;uuml;reselleşme, iklim değişikliği, i&amp;ccedil; savaşlar ve &amp;ccedil;atışmalar ve insan ve hayvan pop&amp;uuml;lasyonları arasında patojen bulaşmasının değişen doğası, bazı riskli b&amp;ouml;lgelerdeki kontrols&amp;uuml;z n&amp;uuml;fus artışı mevcut endişeleri g&amp;uuml;n ge&amp;ccedil;tik&amp;ccedil;e daha da artırmaktadır. Laboratuvar kazalarından veya kasıtlı biyolojik saldırılardan kaynaklanan insan kaynaklı salgınlar ise diğer potansiyel riskler olarak değerlendirilmekte ve uluslararası iş birliği ve koordinasyonu &amp;ouml;nemli kılmaktadır.&amp;nbsp;Uluslararası epidemiyolojik s&amp;uuml;rveyans&amp;nbsp;&amp;lrm;sistemleri ve uluslararası sağlık t&amp;uuml;z&amp;uuml;ğ&amp;uuml; d&amp;uuml;zenlemeleri bulaşıcı hastalıkların salgın boyutlarına&amp;nbsp;&amp;lrm;ulaşmasını &amp;ouml;nlemede ve k&amp;uuml;resel riskleri en aza indirgemede kritik &amp;ouml;nem taşıyan erken m&amp;uuml;dahale uygulamaları ve ara&amp;ccedil;ları olarak etki alanlarını genişletirken, erken uyarı s&amp;uuml;rveyans sistemlerinin etkinliği yeni teknolojilerin de kullanılması ile geliştirilmektedir&amp;lrm;&amp;lrm;.&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;Abstract&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;An elaborate global health system has been developed around the world as a bulwark against&amp;nbsp;&amp;lrm;infectious disease threats. The system consists of various networks of formal and informal organizations serving different stakeholders. This network has different purposes, methods, resources and accountability; it consists of public institutions operating in different fields of influence (at local, national, regional or global level), profit-oriented and non-profit private sector organizations.&amp;nbsp;The current global health system has done important work to protect and improve human health. However, the world continues to face long-standing and emerging or re-emerging infectious disease threats.&amp;nbsp;These threats vary greatly in severity and probability of risk, and each requires separate struggle dynamics. In addition, as with morbidity and mortality rates, these infections have many complex social and economic effects and consequences that differ.&amp;nbsp;&amp;lrm;It is discussed whether the global health system with its current situation can provide effective protection against a number of communicable disease threats.&amp;nbsp;Due to the recent emerging threats of Ebola, Zika, dengue fever, severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), COVID-19, and influenza epidemics, and the increasing threat of antimicrobial resistance, this system is being put to the test.&amp;nbsp;Weak health systems, urbanization, globalization, climate change, civil wars and conflicts, and the changing nature of pathogen transmission between human and animal populations, uncontrolled population growth in some risk areas aggravate current concerns.&amp;nbsp;&amp;quot;Human-induced outbreaks resulting from laboratory accidents&amp;quot; or deliberate biological attacks are considered as other potential risks, making international cooperation and coordination important. International epidemiological surveillance systems and international health regulation coverage are expanding their scope as early intervention practices and tools that are critical in preventing infectious diseases from reaching epidemic levels and minimizing global risks. Also, the effectiveness of early warning surveillance systems is being improved with the use of new technologies&amp;lrm;&amp;lrm;.&lt;/p&gt;</description>
    <description descriptionType="Other">Salgın Hastalıkların Erken Tespiti ve Kontrolünde Küresel Sürveyans ‎Ağları ve ‎Uluslararası Sağlık Tüzüğü</description>
    <description descriptionType="Other">{"references": ["\u200e1. Connolly MA, Heymann DL. Deadly comrades: war and \u200einfectious diseases. Lancet 2002; 360 Suppl: s23-4.", "\u200e2. Graversen VK, Hamichi SE, Gold A, Murray TG. History \u200ethrough the eyes of a pandemic. Curr Opin Ophthalmol \u200e\u200e\u200e2020; 31(6): 538-48.", "\u200e3. Peset JL. Plagues and Diseases in History. In: Wright \u200eJD (ed), International Encyclopedia of the Social &amp; \u200e\u200eBehavioral Sciences (2nd edition). 2015, Elsevier. \u200epp:174-9.", "\u200e4. Henderson DA. The eradication of smallpox--an \u200eoverview of the past, present, and future. Vaccine 2011; \u200e\u200e29 \u200eSuppl 4: D7-9.", "\u200e5. Krammer F. SARS-CoV-2 vaccines in development. \u200eNature 2020; 586(7830): 516-27.", "\u200e6. Nehme M, Stringhini S, Guessous I, SEROCoV-Pop \u200eStudy Team. Perceptions of immunity and vaccination \u200e\u200ecertificates among the general population: a nested study \u200ewithin a serosurvey of anti-SARS-CoV-2 antibodies \u200e\u200e\u200e(SEROCoV-POP). Swiss Med Wkly 2020; 150: w20398.", "\u200e7. Behbehani AM. The smallpox story: life and death of \u200ean old disease. Microbiol Rev 1983; 47(4): 455-509.", "\u200e8. Reperant LA, Osterhaus ADME. AIDS, Avian flu, SARS, \u200eMERS, Ebola, Zika\u2026 what next? Vaccine 2017; 35(35 Pt \u200e\u200eA): 4470-4.", "\u200e9. Bloom DE, Cadarette D. Infectious Disease Threats in \u200ethe Twenty-First Century: Strengthening the Global \u200e\u200eResponse. Front Immunol 2019; 10: 549.", "\u200e10. Zhukova A, Blassel L, Lemoine F, Morel M, Voznica J, \u200eGascuel O. Origin, evolution and global spread of SARS-\u200e\u200eCoV-2. C R Biol 2020 [Epub ahead of print]", "\u200e11. Smith KF, Goldberg M, Rosenthal S, Carlson L, Chen \u200eJ, Chen C, et al. Global rise in human infectious disease \u200e\u200eoutbreaks. J R Soc Interface 2014; 11(101): 20140950.", "\u200e12. World Health Organization (WHO), Geneva, \u200eSwitzerland. WHO Coronavirus Disease (COVID-19) \u200eDashboard. \u200eAvailable at: https://covid19.who.int/ \u200e\u200e[Accessed January 10, 2022]. \u200e", "\u200e13. Lazcano-Ponce E, Allen B, Gonz\u00e1lez CC. The \u200econtribution of international agencies to the control of \u200e\u200ecommunicable diseases. Arch Med Res 2005; 36(6): 731-\u200e\u200e8. \u200e", "\u200e14. World Health Organization (WHO), Geneva, \u200eSwitzerland. Communicable Diseases. Available at: \u200e\u200ehttps://www.who.int/about/structure/organigram/htm/en/ \u200e\u200e[Accessed April 11, 2021].\u200e", "\u200e15. Raviglione M, Maher D. Ending infectious diseases in \u200ethe era of the Sustainable Development Goals. Porto \u200e\u200eBiomed J 2017; 2(5): 140-2. \u200e", "\u200e16. Christaki E. New technologies in predicting, \u200epreventing and controlling emerging infectious diseases. \u200eVirulence \u200e\u200e2015; 6(6): 558-65. \u200e", "\u200e17. Rolland C, Lazarus C, Giese C, Monate B, Travert AS, \u200eSalomon J. Early Detection of Public Health Emergencies \u200e\u200eof International Concern through Undiagnosed Disease \u200eReports in ProMED-Mail. Emerg Infect Dis 2020; 26(2): \u200e\u200e\u200e336-9. \u200e", "\u200e18. Mykhalovskiy E, Weir L. The Global Public Health \u200eIntelligence Network and early warning outbreak \u200edetection: a \u200eCanadian contribution to global public health. \u200eCan J Public Health 2006; 97(1): 42-4. \u200e\u200e \u200e", "\u200e19. \u015eahiner F, Ard\u0131\u00e7 N. An Update on Ebolavirus \u200eEpidemiology and Experimental Modalities. Dis Mol Med \u200e\u200e2016; \u200e\u200e4(4): 43-50. \u200e", "\u200e20. Ho\u015fbul T, \u015eahiner F. Genomic and Biologic \u200eCharacteristics of SARS-CoV-2 and Other Coronaviruses. J \u200eMol Virol \u200eImmunol 2020; 1(1): 18-29. \u200e", "\u200e21. Raoult D, Zumla A, Locatelli F, Ippolito G, Kroemer G. \u200eCoronavirus infections: Epidemiological, clinical and \u200e\u200eimmunological features and hypotheses. Cell Stress 2020; \u200e\u200e4(4): 66-75. \u200e", "\u200e22. S\u00fcmb\u00fcl HE, \u015eahiner F. Rapid Spreading of SARS-CoV-\u200e\u200e2 Infection and Risk Factors: Epidemiological, \u200e\u200eImmunological and Virological Aspects. J Mol Virol \u200eImmunol 2020; 1(2): 36-50. \u200e", "\u200e23. Institute of Medicine (US) Forum on Microbial \u200eThreats. Global Infectious Disease Surveillance and \u200eDetection: \u200eAssessing the Challenges, 1st ed. Washington, \u200eNational Academies Press, 2007: 107-57. \u200e\u200e \u200e", "\u200e24. Akkurt SS. Ki\u015fisel Sa\u011fl\u0131k Verilerinin \u0130\u015flenmesine ve \u200eCovid19 Pandemisi S\u00fcrecinde Mobil Uygulamalarla \u200e\u200ePayla\u015f\u0131lmas\u0131na Hukuk\u00ee Bir Bak\u0131\u015f. \u0130stanbul Ticaret \u200e\u00dcniversitesi Sosyal Bilimler Dergisi 2020; 2 (Covid-19 \u00d6zel \u200eEk): \u200e\u200e142-160. \u200e", "\u200e25. Marsh R, Pilkington P, Rice L. A guide to architecture \u200efor the public health workforce. Public Health 2020; 178: \u200e\u200e\u200e120-3. \u200e", "\u200e26. Durrheim DN, Andrus JK. The ethical case for global \u200emeasles eradication-justice and the Rule of Rescue. Int \u200e\u200eHealth 2020; 12(5): 375-7. \u200e", "\u200e27. World Health Organization (WHO), Geneva, \u200eSwitzerland. International Health Regulations (2005). \u200eAvailable at: \u200e\u200ehttps://www.who.int/publications/i/item/9789241580410. \u200e\u200e[Accessed April 11, 2021]. \u200e", "\u200e28. Davies SE. Infectious Disease Outbreak Response: \u200eMind the Rights Gap. Med Law Rev 2017; 25(2): 270-92. \u200e\u200e \u200e", "\u200e29. United Nations Office for the Coordination of \u200eHumanitarian Affairs (OCHA), UN, New York, USA. Report \u200eof the \u200eHigh-Level Panel on the Global Response to Health \u200eCrises (25 January 2016). Available at: \u200e\u200ehttp://reliefweb.int/sites/reliefweb.int/files/resources/2016\u200e\u200e-02-\u200e\u200e\u200e05_Final_Report_Global_Response_to_Health_Crises.pdf. \u200e\u200e[Accessed April 11, 2021]. \u200e", "\u200e30. Wong MC, Huang J, Wong SH, Yuen-Chun Teoh J. \u200eThe potential effectiveness of the WHO International \u200eHealth \u200eRegulations capacity requirements on control of \u200ethe COVID-19 pandemic: a cross-sectional study of 114 \u200ecountries. \u200eJ R Soc Med 2021; 114(3): 121-31. \u200e\u200e\u200e", "\u200e31. G\u00fcner \u00d6, Buzgan T. The First Three Months of the \u200eCOVID-19 Pandemic: The World Health Organization's \u200eResponse. J \u200eMol Virol Immunol 2021; 2(3): 86-101. \u200e\u200e\u200e"]}</description>
  </descriptions>
</resource>
28
35
views
downloads
Views 28
Downloads 35
Data volume 18.8 MB
Unique views 23
Unique downloads 31

Share

Cite as